Gene · 316
Papers2,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes: Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia. | Pharmaceuticals (Basel) | 2026 | 41754808 | PubTator, text mining | PubMed |
| Epigenetic Regulation of the BDNF Gene by Molybdenum in 9 to 11-Year-Old Children: A Targeted Gene DNA Methylation Study. | Mol Nutr Food Res | 2026 | 41749487 | PubTator, text mining | PubMed |
| UHPLC-MS/MS Quantification of Human Cytosolic Aldehyde Oxidase: Heat-Assisted In-Solution Protein Denaturation and Digestion. | Rapid Commun Mass Spectrom | 2026 | 41736555 | PubTator, text mining | PubMed |
| The Role of Metabolites in Acyclovir-Induced Neurotoxicity and Nephrotoxicity. | Medicines (Basel) | 2026 | 41718166 | PubTator, text mining | PubMed |
| Pichia-CLM: A language model-based codon optimization pipeline for Komagataella phaffii. | Proc Natl Acad Sci U S A | 2026 | 41701818 | PubTator, text mining | PubMed |
| Deuterium modification of tyrosine kinase inhibitors contributes to reversing ferroptosis resistance through upregulation of aldehyde oxidase 1 in hepatocellular carcinoma. | Acta Pharm Sin B | 2026 | 41685141 | PubTator, text mining | PubMed |
| Proteomic Profiling of Human Omental and Subcutaneous Adipose Tissue in Individuals with a Broad Range of BMI. | bioRxiv | 2026 | 41648401 | PubTator, text mining | PubMed |
| Antiplasmodial Activity and Pharmacokinetic Profiling of Cryptolepine and 2,7-Dibromocryptolepine With a View to Informing the Design of Novel Antimalarial Cryptolepine Analogues. | Drug Dev Res | 2026 | 41631973 | PubTator, text mining | PubMed |
| Retrospection of the USFDA-Approved Halogenated Drugs and Their Implication in Medicinal Chemistry and Drug Discovery: A Perspective of Approved Drugs Between 2019 and 2024. | Arch Pharm (Weinheim) | 2026 | 41556324 | PubTator, text mining | PubMed |
| Pharmacogenomics of Thiopurine Drugs: A Bench-To-Bedside Success Story in Thailand. | Clin Transl Sci | 2026 | 41555632 | PubTator, text mining | PubMed |
| Mechanism-based inactivation of human aldehyde oxidase by erlotinib: Mechanistic insights from structural analogs and molecular docking. | Mol Pharmacol | 2026 | 41494457 | PubTator, text mining | PubMed |
| Corrigendum to "Aldehyde oxidase 1 promotes gallbladder carcinogenesis through ROS-mediated activation of the Wnt/β-catenin pathway" [Cellular Signalling, 116 (2024) 111042]. | Cell Signal | 2026 | 41224574 | PubTator, text mining | PubMed |
| Multi-omics integration reveals CYP2B6 as a central node in the molecular landscape of non-small cell lung cancer. | Med Oncol | 2025 | 41405767 | PubTator, text mining | PubMed |
| Repurposing clinically safe drugs for DNA repair pathway choice in CRISPR genome editing and synthetic lethality. | Nat Commun | 2025 | 41372233 | PubTator, text mining | PubMed |
| Comprehensive androgen-dependent transcriptome analysis in human genital tissue. | BMC Genomics | 2025 | 41249932 | PubTator, text mining | PubMed |
| Quetiapine competitively inhibits aldehyde oxidase-mediated reduction. | Drug Metab Dispos | 2025 | 41100927 | PubTator, text mining | PubMed |
| Structure and properties of an oxidative metabolite of 2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide generated by aldehyde oxidase. | Drug Metab Dispos | 2025 | 41037999 | PubTator, text mining | PubMed |
| Overexpression of alcohol dehydrogenase 1 A inhibits the progress of triple negative breast cancer via Wnt/β-catenin signaling. | Sci Rep | 2025 | 41006587 | PubTator, text mining | PubMed |
| Oxidative Stress and Antioxidant Therapies in Friedreich's Ataxia. | Cells | 2025 | 41002373 | PubTator, text mining | PubMed |
| Production of recombinant human G protein-coupled estrogen receptor (GPER) and establishment of a ligand binding assay using graphene quantum dots (GQDs). | PLoS One | 2025 | 40972003 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/316/papers?page=2